CIC
HITK

Cornercap Investment Counsel’s HI-TECH PHARMACAL INC HITK Stock Holding History

Cornercap Investment Counsel’s Portfolio HITK Stock Details HITK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-9,875
Closed -$328K – 279
2013
Q2 		$328K Buy
+9,875
New +$329K 0.07% 135

Other funds holding HITK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Cornercap Investment Counsel's HITK Position: Q3 2013 in Review

Cornercap Investment Counsel sold out of HI-TECH PHARMACAL INC (HITK) in Q3 2013, closing a stake of 9,875 shares — an estimated $328K sold.

Cornercap Investment Counsel first reported a position in HITK in Q2 2013 and held it in 1 quarter. The position peaked at $328K in Q2 2013. 105 funds tracked by Wall St. Rank hold HITK as of Q3 2013.

  • Cornercap Investment Counsel reported no remaining HI-TECH PHARMACAL INC position as of Q3 2013 after selling out during the quarter.
  • Cornercap Investment Counsel sold 9,875 HI-TECH PHARMACAL INC shares in Q3 2013, an estimated $328K.
  • Cornercap Investment Counsel first reported a position in HI-TECH PHARMACAL INC in Q2 2013 and held it in 1 quarter.
  • Cornercap Investment Counsel's HI-TECH PHARMACAL INC position peaked at $328K in Q2 2013.
  • 105 funds tracked by Wall St. Rank held HI-TECH PHARMACAL INC as of Q3 2013.

Based on Cornercap Investment Counsel's 13F filing for Q3 2013, filed 14 Nov 2013.